These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2670325)

  • 1. AHA Conference Report on Cholesterol. Intervention studies.
    Levy RI; Blankenhorn D; Davis CE; Gordon DJ; Furberg C; Huttunen J; Levine RJ; Passamani E; Yusuf S
    Circulation; 1989 Sep; 80(3):739-43. PubMed ID: 2670325
    [No Abstract]   [Full Text] [Related]  

  • 2. AHA Conference Report on Cholesterol. Drug therapy.
    Havel RJ; Davignon J; Dujovne CA; Gregg R; Hunninghake DB; Miettinen T; Steinbrecher U; Tobert JA
    Circulation; 1989 Sep; 80(3):744-8. PubMed ID: 2670326
    [No Abstract]   [Full Text] [Related]  

  • 3. Trial of an anabolic steroid (oxymetholone) in atherosclerosis with hyperlipoproteinaemia.
    Barton GM; Gillam PM; Longridge RG; Freeman PR
    Atherosclerosis; 1973; 18(3):505-7. PubMed ID: 4356387
    [No Abstract]   [Full Text] [Related]  

  • 4. AHA Conference Report on Cholesterol. Diagnosis, evaluation, and treatment: current status and issues.
    Goodman DS; Bradford RH; Brewer HB; Brunzell JD; Cleeman JI; Greenland P; Hulley SB; Naito HK; Rifkind B; Stein E
    Circulation; 1989 Sep; 80(3):735-8. PubMed ID: 2670324
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical experiences with SPN 40150 in hyperlipidemia and arteriosclerotic circulatory disturbances (author's transl)].
    Schimert G
    MMW Munch Med Wochenschr; 1974 Feb; 116(8):389-92. PubMed ID: 4208098
    [No Abstract]   [Full Text] [Related]  

  • 6. AHA Conference Report on Cholesterol. Basis for dietary treatment.
    Grundy SM; Brown WV; Dietschy JM; Ginsberg H; Goodnight S; Howard B; La Rosa JC; McGill HC
    Circulation; 1989 Sep; 80(3):729-34. PubMed ID: 2670323
    [No Abstract]   [Full Text] [Related]  

  • 7. Diet and drug treatment of hyperlipidemia and atherosclerosis.
    Kuo PT
    Ann Clin Lab Sci (1971); 1972; 2(4):322-4. PubMed ID: 4342101
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hyperlipemia: clinico-therapeutic experience with a heparinoid].
    De Martino G; D'Aniello L; De Simone E; Belli MG; Buonfantino M
    Clin Ter; 1978 Sep; 86(6):583-95. PubMed ID: 83925
    [No Abstract]   [Full Text] [Related]  

  • 9. [The importance of determining the type of hyperlipidemia for lipotropic therapy of atherosclerosis].
    Bavina MV; Perova NV; Lobova NM; Koropova GI
    Kardiologiia; 1973 Mar; 13(3):27-33. PubMed ID: 4717180
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of rapid screening methods for the detection of abnormal lipid states related to atherosclerosis.
    Boyle E; Dash HH; Owen D; Yarmosh D
    Ann Clin Lab Sci (1971); 1972; 2(5):393-403. PubMed ID: 4343280
    [No Abstract]   [Full Text] [Related]  

  • 11. AHA Conference Report on Cholesterol.
    Circulation; 1989 Sep; 80(3):715-48. PubMed ID: 2670320
    [No Abstract]   [Full Text] [Related]  

  • 12. [Plasma lipid-normalizing activity of the combination of ethylchlorophenoxyisobutyrate and duodenal sulfomucopolysaccharide extract].
    Sabella G
    Farmaco Prat; 1967 Dec; 22(12):786-94. PubMed ID: 4238407
    [No Abstract]   [Full Text] [Related]  

  • 13. Elevated remnant-like particle cholesterol concentration: a characteristic feature of the atherogenic lipoprotein phenotype.
    Twickler TB; Dallinga-Thie GM; Cohn JS; Chapman MJ
    Circulation; 2004 Apr; 109(16):1918-25. PubMed ID: 15117861
    [No Abstract]   [Full Text] [Related]  

  • 14. Expression of an atherogenic dyslipidemic phenotype in the postprandial period.
    Twickler M; Cramer MJ; Erkelens W
    Am J Cardiol; 2003 Jan; 91(2):258. PubMed ID: 12521649
    [No Abstract]   [Full Text] [Related]  

  • 15. An update on the hyperlipidemias and atherosclerosis.
    Powell RC
    Indiana Med; 1984 Jun; 77(6):441-5. PubMed ID: 6736617
    [No Abstract]   [Full Text] [Related]  

  • 16. Aha committee report. Diet in the healthy child.
    Circulation; 1983 Jun; 67(6):1411A-1414A. PubMed ID: 6851035
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of Xiaoyu tablet on blood lipid and lipoproteins in hyperlipidemic rabbits with atherosclerosis.
    Xie ML; Gu ZL; Zhu LJ
    Chin Med J (Engl); 2005 Oct; 118(19):1651-3. PubMed ID: 16232351
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hypolipemic effects of a new tetralin derivative: compound 13473-Su (Ciba)].
    Ciobanu V; Zălaru MC; Ciocan A; Mihăilescu S
    Stud Cercet Med Interna; 1971; 12(1):67-80. PubMed ID: 5565781
    [No Abstract]   [Full Text] [Related]  

  • 19. Lowering of serum cholesterol and triglyceride by para-aminosalicylic acid in hyperlipoproteinemia. Studies in patients with types II-A and II-B.
    Barter PJ; Connor WE; Spector AA; Armstrong M; Connor SL; Newman MA
    Ann Intern Med; 1974 Nov; 81(5):619-24. PubMed ID: 4609028
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diphosphonate (disodium etidronate) lowers cholesterol and total lipid levels in the blood of humans].
    Caniggia A; Gennari C; Picchi M
    Boll Soc Ital Biol Sper; 1974 Sep; 50(17):1416-22. PubMed ID: 4218488
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.